SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oxford Health Plan (OXHP)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Lee A. Rosin who wrote ()11/17/1997 9:30:00 AM
From: Worswick  Read Replies (2) of 2068
 
Marcie

It is probably inevitable that OXHP is bought out because management doesn't have enough ownership to stop it and they own only 6.5% of the common. Perhaps as many as 60% of the shares in OXHP have traded in the last three weeks. So... given that a buyout is inevitable who shall it be: Aetna? Cigna? Prudential?

Then, what is the price? 1.3 cash flow? At $4.1 billion cash flow that is $5.4 billion. 1.5 cash flow: $6.l5 billion. Divide by 78.8 million shares: that is, $68 to $78 a share on the low side. One goes up from here to two times and three times cash flow

Remember that in October the S&P mid cap report said that a fair value for OXHP was $102. a share. AT THAT the same service said that Intel was fairly valued at $77 a share. A basis of comparison of this service and it's tough minded ratings.

The only question here is probably the price. Unfortunately. I'd love to hold this stock for ten years. It is a great company with one or two warts. Not cancer.

Let's get some feedback. This thread is tired. And this is real money were talking aobut here.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext